Exclusive: Therapists and Trialists from Lykos’ Phase 3 MDMA-Assisted Therapy Studies Push Back on ICER’s Critical Draft Report

Late last month, the Institute for Clinical and Economic Review (ICER) published its draft evidence report on Lykos Therapeutics’ MDMA-assisted psychotherapy (which it abbreviates to ‘MDMA-AP’) for the treatment of PTSD. For more detail, see our coverage.Since then, we have shared several responses from the likes of researchers and market access professionals. For its part…

Source